Advancing Stroke Care: Dual Antiplatelet Therapy Shows Promise in New Study

Topline

Dual antiplatelet therapy (DAPT) with clopidogrel-aspirin administered within 72 hours of a mild ischemic stroke or high-risk transient ischemic attack (TIA) significantly reduces the risk of new stroke compared to aspirin alone, despite a higher bleeding risk - findings from the INSPIRES trial. #StrokePrevention #MedicalResearch

Study Details